Effects of platelet activating factor receptor antagonist in intestinal mucin-2 during endotoxemia on young rats

OBJECTIVE: This study aimed to investigate the roles of platelet activating factor (PAF) receptor antagonist in damage to intestinal mucin-2 (MUC2) during endotoxemia on young rats

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 46(2008), 9 vom: 22. Sept., Seite 680-3
1. Verfasser: Wang, Li-jie (VerfasserIn)
Weitere Verfasser: Sun, Mei
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2008
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:English Abstract Journal Article Mucin-2 Platelet Membrane Glycoproteins Receptors, G-Protein-Coupled platelet activating factor receptor
LEADER 01000caa a22002652 4500
001 NLM185336027
003 DE-627
005 20250210012029.0
007 tu
008 231223s2008 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0618.xml 
035 |a (DE-627)NLM185336027 
035 |a (NLM)19099858 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Wang, Li-jie  |e verfasserin  |4 aut 
245 1 0 |a Effects of platelet activating factor receptor antagonist in intestinal mucin-2 during endotoxemia on young rats 
264 1 |c 2008 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 02.12.2010 
500 |a Date Revised 07.06.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: This study aimed to investigate the roles of platelet activating factor (PAF) receptor antagonist in damage to intestinal mucin-2 (MUC2) during endotoxemia on young rats 
520 |a METHODS: Eighteen-day-old Wistar rats were randomized to be treated with lipopolysaccharide (LPS) (5 mg/kg), LPS plus PAF receptor antagonist and normal saline injection (control). PAF receptor antagonist BN52021 5 mg/kg was administered 30 minutes before or after LPS injection (pretreatment group or treatment group). The ileum specimens (n = 8) were harvested at 1.5, 3, 6, 24, 48 and 72 hours after LPS injection. Transmission electron microscopy was used for morphologic evaluation. Immunohistochemistry was used to determine MUC2 in intestinal mucosa 
520 |a RESULTS: Microvilli and tight junctions were intact in the control group. Enlargement of tight junctions were seen in the LPS group and microvilli were thin, rare or disrupted, shed. The rough endoplasmic reticulum, mitochondria, and glycogen particles were injured. The changes of the pretreatment and treatment group were slightly milder than that in the LPS group. Ileum of a control rat in which a thin layer of mucus covering the epithelial surface and mucin-containing goblet cells appeared very distended. The experiment group showed a decrease or irregularly distributed membranous mucus expression. The MUC2 content of absorbance significantly decreased in the LPS challenged group compared with that in the control group (P < 0.01), and reached a nadir at 6 hours (0.1841 +/- 0.0047) vs. the control group (0.2091 +/- 0.0060) (P < 0.01). The tendency of the level of MUC2 in the pretreatment and treatment group was the same as that of the LPS group, and the level of MUC2 in the pretreatment and treatment group was higher than that in the LPS group at each time point. ANOVA analysis showed that the inter-group and intra-group difference had statistical significance (P < 0.05) 
520 |a CONCLUSIONS: PAF may play some roles in the injury of intestinal mucus barrier function during endotoxemia. Preventive and remedial use of PAF receptor antagonist BN52021 may relieve intestinal injury 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a Mucin-2  |2 NLM 
650 7 |a Platelet Membrane Glycoproteins  |2 NLM 
650 7 |a Receptors, G-Protein-Coupled  |2 NLM 
650 7 |a platelet activating factor receptor  |2 NLM 
700 1 |a Sun, Mei  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 46(2008), 9 vom: 22. Sept., Seite 680-3  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:46  |g year:2008  |g number:9  |g day:22  |g month:09  |g pages:680-3 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 46  |j 2008  |e 9  |b 22  |c 09  |h 680-3